While the Netherlands was in lockdown because of the coronavirus, Ph.D. candidate Koen Rijpkema began his research into the ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Among the various plastic recycling methods being explored, one promising approach is biological plastic recycling, also ...

Gain Therapeutics, Inc. (NASDAQ: GANX) shares -made miniscule gains Friday. The Bethesda, Md.-based firm, a clinical-stage biotechnology company leading the discovery and development of the next ...

New findings show heat-stable enzymes use flexible regions to maintain activity, guiding design of improved catalysts for PET ...

While the Netherlands was in lockdown because of the coronavirus, PhD candidate Koen Rijpkema began his research into the ...

Scientists have gained tremendous control over the genome with CRISPR editing systems, that use a guide RNA molecule to ...

Harnessing technology transferred from VTT Technical Research Centre of Finland, Proteins.1 is developing a PCR-like ...

Researchers have developed a smaller pair of “molecular scissors” for gene editing, based on a group of enzymes called Cas12f ...

To fight viruses, bacteria have evolved a way to make new DNA without copying it.

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting ...

New analytical methods developed at Baylor College of Medicine and collaborating institutions have increased our understanding of how bacteria manage DNA. The methods enabled researchers to uncover ...